The alternative (“alt-“) animal products industry is growing increasingly more popular each year, causing an increased demand in foods madeContinue Reading Foodtech Patents: Who’s on the Board and What Moves are they Making?
Gene therapies have been the subject of tremendous scientific research and investment. With hundreds of clinical trials in progress and…Continue Reading The Evolving Gene Editing Landscape: From Research Tool to Market
Substantial patent litigation activity occurred in the mRNA space in 2022, involving nearly all of the major mRNA and lipid…Continue Reading mRNA IP 2022 Year in Review: Pioneers Clash in Major Patent Litigations
Great buzz resulted from the World Bank study showing that the fashion industry is responsible for about 10% of annual…Continue Reading Upcycling: A Question of Law and Optics
Web3, the up-and-coming decentralized iteration of the World Wide Web built on the blockchain, presents a unique opportunity for fashion…
Continue Reading Fashion Meets Web3 – Protecting Emerging Phygital Fashion Innovations
Several patent litigations have been filed involving mRNA pioneers such as Moderna, Inc. and BioNTech, Inc. (with Pfizer) over the…
Continue Reading The Current mRNA/LNP Patent Litigation Landscape
On August 16, 2022, Merck (NYSE: MRK) and Orna Therapeutics each announced that they entered into a collaboration agreement relating…
Continue Reading Merck and Orna Therapeutics Join Forces in Circular RNA Collaboration
In light of Elon Musk’s recent offer to buy Twitter, Inc. (“Twitter”) there has been a resurgence in the desire…
Continue Reading Increased Innovation in Decentralized Social Networks Space Spurred By Ownership Uncertainty of Traditional Platforms
The food tech industry has been rapidly growing in recent years with the rise in popularity of alternative (“alt-“)…
Continue Reading Foodtech Pioneer Impossible Foods Sues Competitor Motif for Patent Infringement
In April of 2021, we provided a three-part series relating to the IP and Competitive Landscape for the mRNA market.
Continue Reading mRNA Patent and Competitive Landscape: 2021 Year in Review and 2022 Outlook